Viking Therapeutics is a clinical-stage biotech company focused on developing weight-loss therapies. Read why I rate VKTX ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Oral dissolvable drugs also allow people to ... Found launches new program to assist employers in managing obesity care, including GLP-1 drugs GLP-1 drugs are administered by companies in ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight loss medications known as GLP-1 receptor agonists, including the popular name brands Ozempic ...

GLP-1 medications are also not currently approved for women who are pregnant, and they might interact with some medications. For example, if used with glipizide or insulin, it can increase your ...